---
figid: PMC6757184__bsr-39-bsr20192466-g1
figtitle: Wnt/Beta-catenin signaling as a useful therapeutic target in hepatoblastoma
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC6757184
filename: bsr-39-bsr20192466-g1.jpg
figlink: /pmc/articles/PMC6757184/figure/F1/
number: F1
caption: 'There may be activation of glypican-3, NF-kB, GSK-3β, ERK1/2 and/or co-activator
  of β-catenin, i.e. FHL2. Activation of β-catenin signaling may induce different
  pathways to induce the development of hepatoblastoma including inhibition of TNF-α-dependent
  apoptosis, increase in the secretion of epithelial growth factor (EGF) and formation
  of complex of β-catenin with YAP-1 protein. This interaction may activate mTOR pathway
  to increase the expression of SLC38A1 (amino acid transporter) that may be critical
  in the development of hepatoblastoma. Abbreviations: mTOR, mammalian target of rapamycin;
  TNF-α, tumor necrosis factor-α.'
papertitle: Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma.
reftext: Ying-Li Sha, et al. Biosci Rep. 2019 Sep 30;39(9):BSR20192466.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9401131
figid_alias: PMC6757184__F1
figtype: Figure
redirect_from: /figures/PMC6757184__F1
ndex: 2c3e8e14-dec2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6757184__bsr-39-bsr20192466-g1.html
  '@type': Dataset
  description: 'There may be activation of glypican-3, NF-kB, GSK-3β, ERK1/2 and/or
    co-activator of β-catenin, i.e. FHL2. Activation of β-catenin signaling may induce
    different pathways to induce the development of hepatoblastoma including inhibition
    of TNF-α-dependent apoptosis, increase in the secretion of epithelial growth factor
    (EGF) and formation of complex of β-catenin with YAP-1 protein. This interaction
    may activate mTOR pathway to increase the expression of SLC38A1 (amino acid transporter)
    that may be critical in the development of hepatoblastoma. Abbreviations: mTOR,
    mammalian target of rapamycin; TNF-α, tumor necrosis factor-α.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CTNNB1
  - MAPK3
  - MAPK1
  - FHL2
  - GSK3B
  - NFKB1
  - TNF
  - EGF
  - SLC38A1
  - Hepatoblastoma
---
